PIK3CA and neoplasm: Since crosstalk and compensatory mechanisms exist between the PI3K/Akt and MAPK/ERK pathways, especially in tumor cells [46,47], the effect of the inhibitors after a short-term treatment may not reflect the ultimate effect that is achieved by long-term treatment.